Hamilton, John
Hamilton, John was paid $11.75M by Medicaid between Jan 2018 and Nov 2024, across 193 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 13% of everything it billed.
PARK RIDGE, IL 60068
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 343,320 | $1.47M | |
| 2019 | 364,595 | $1.59M | |
| 2020 | 362,500 | $1.69M | |
| 2021 | 311,614 | $2.47M | |
| 2022 | 323,546 | $2.86M | |
| 2023 | 245,459 | $1.66M | |
| 2024incomplete | 113 | $4K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 26,149 | 18,163 | $1.56M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 9.7% | 15,152 | 14,339 | $1.14M |
| 80053 | Comprehensive metabolic panel | 7.5% | 176,393 | 93,320 | $886K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 5.1% | 3,563 | 3,085 | $598K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.1% | 209,011 | 108,562 | $598K |
| 83735 | 3.7% | 116,730 | 34,600 | $439K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.4% | 98,324 | 36,384 | $399K |
| 83880 | 2.8% | 32,721 | 15,807 | $333K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.4% | 11,835 | 10,425 | $281K |
| 82803 | 2.1% | 33,541 | 14,343 | $246K | |
| 85027 | 1.8% | 74,651 | 31,500 | $217K | |
| 82330 | 1.8% | 30,203 | 5,574 | $211K |
181 more codes
| 87641 | 1.6% | 8,568 | $194K | |
| 83605 | 1.6% | 42,793 | $186K | |
| 82805 | 1.6% | 25,677 | $185K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 7,992 | $179K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.5% | 7,939 | $178K |
| 87040 | 1.5% | 22,242 | $177K | |
| 84484 | 1.4% | 42,600 | $165K | |
| 85730 | 1.3% | 48,674 | $158K | |
| 84100 | 1.2% | 63,934 | $143K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 5,108 | $134K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 16,133 | $131K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 24,480 | $128K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.1% | 5,080 | $126K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 3,617 | $125K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.0% | 2,422 | $118K |
| 85610 | <1% | 54,174 | $108K | |
| 86901 | <1% | 47,092 | $108K | |
| 83690 | <1% | 25,336 | $88K | |
| 86900 | <1% | 47,121 | $80K | |
| 88307 | <1% | 1,471 | $73K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,184 | $73K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,163 | $72K |
| 86850 | <1% | 23,023 | $67K | |
| 81001 | <1% | 44,535 | $64K | |
| 84703 | <1% | 18,154 | $63K | |
| 87507 | <1% | 389 | $59K | |
| 82375 | <1% | 25,436 | $54K | |
| 84132 | <1% | 28,778 | $53K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,725 | $49K |
| 85379 | <1% | 12,393 | $49K | |
| 83615 | <1% | 18,520 | $49K | |
| 86140 | <1% | 20,338 | $47K | |
| 87493 | <1% | 1,775 | $39K | |
| 83050 | <1% | 27,215 | $37K | |
| 87186 | <1% | 5,761 | $37K | |
| 82728 | <1% | 9,392 | $36K | |
| 80202 | <1% | 5,296 | $36K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,519 | $36K |
| 87075 | <1% | 5,256 | $34K | |
| 84295 | <1% | 20,975 | $33K | |
| 85384 | <1% | 10,026 | $32K | |
| 82248 | <1% | 15,414 | $32K | |
| 82247 | <1% | 13,136 | $30K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,494 | $28K |
| 85018 | <1% | 28,668 | $28K | |
| 82607 | <1% | 4,552 | $27K | |
| 84439 | <1% | 6,279 | $27K | |
| 80061 | Lipid panel | <1% | 8,265 | $26K |
| 84702 | <1% | 6,055 | $26K | |
| 82550 | <1% | 8,210 | $26K | |
| 87070 | <1% | 7,790 | $25K | |
| 87340 | <1% | 3,594 | $24K | |
| 82746 | <1% | 4,119 | $23K | |
| 83550 | <1% | 5,265 | $22K | |
| 84145 | <1% | 5,684 | $21K | |
| 87210 | <1% | 8,520 | $19K | |
| 83970 | <1% | 1,224 | $19K | |
| 87205 | <1% | 9,919 | $18K | |
| 87088 | <1% | 3,061 | $18K | |
| 82077 | <1% | 1,630 | $17K | |
| 82140 | <1% | 4,185 | $17K | |
| 86706 | <1% | 2,398 | $17K | |
| 82570 | <1% | 7,119 | $17K | |
| 86803 | <1% | 1,939 | $16K | |
| 86665 | <1% | 1,382 | $16K | |
| 80074 | <1% | 875 | $16K | |
| 87081 | <1% | 5,605 | $16K | |
| 86235 | <1% | 941 | $16K | |
| 86704 | <1% | 1,896 | $15K | |
| 85046 | <1% | 5,297 | $14K | |
| 87077 | <1% | 5,195 | $14K | |
| 80076 | <1% | 3,611 | $13K | |
| 87015 | <1% | 3,266 | $12K | |
| 86870 | <1% | 1,629 | $12K | |
| 81003 | <1% | 11,164 | $12K | |
| 85652 | <1% | 8,979 | $12K | |
| 89051 | <1% | 3,553 | $11K | |
| 88304 | <1% | 645 | $11K | |
| 86077 | <1% | 409 | $11K | |
| 87806 | <1% | 1,150 | $11K | |
| 80197 | <1% | 2,099 | $11K | |
| 86920 | <1% | 3,459 | $11K | |
| 82533 | <1% | 1,363 | $9K | |
| 82565 | <1% | 4,542 | $9K | |
| 87102 | <1% | 2,498 | $9K | |
| 84478 | <1% | 4,128 | $9K | |
| 84481 | <1% | 1,778 | $9K | |
| 83655 | <1% | 1,432 | $8K | |
| 87116 | <1% | 1,347 | $8K | |
| 88342 | <1% | 672 | $8K | |
| 80143 | <1% | 666 | $8K | |
| 80179 | <1% | 661 | $8K | |
| 82150 | <1% | 2,119 | $8K | |
| 86038 | <1% | 966 | $8K | |
| 86480 | <1% | 292 | $8K | |
| 82784 | <1% | 1,343 | $7K | |
| 85014 | <1% | 7,557 | $7K | |
| 86880 | <1% | 2,217 | $7K | |
| 83540 | <1% | 2,151 | $6K | |
| 87206 | <1% | 2,677 | $6K | |
| 86592 | <1% | 3,188 | $6K | |
| 84156 | <1% | 5,623 | $6K | |
| 80164 | <1% | 1,361 | $6K | |
| 84300 | <1% | 2,758 | $6K | |
| 82947 | <1% | 3,678 | $6K | |
| 82962 | <1% | 5,597 | $5K | |
| 81025 | <1% | 2,829 | $5K | |
| 87483 | <1% | 30 | $5K | |
| 87807 | <1% | 1,135 | $5K | |
| 86985 | <1% | 1,271 | $5K | |
| 84550 | <1% | 2,527 | $5K | |
| 83930 | <1% | 1,780 | $4K | |
| 0240U | <1% | 54 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 167 | $4K |
| 86762 | <1% | 858 | $4K | |
| 87449 | <1% | 448 | $3K | |
| 82945 | <1% | 2,014 | $3K | |
| 82010 | <1% | 1,136 | $3K | |
| 83516 | <1% | 399 | $3K | |
| 83010 | <1% | 656 | $3K | |
| 86922 | <1% | 309 | $3K | |
| 83935 | <1% | 1,130 | $3K | |
| 84157 | <1% | 2,190 | $3K | |
| 86308 | <1% | 1,134 | $3K | |
| 87497 | <1% | 109 | $2K | |
| 86945 | <1% | 730 | $2K | |
| 86769 | <1% | 90 | $2K | |
| 86225 | <1% | 391 | $2K | |
| 87653 | <1% | 79 | $2K | |
| 84520 | <1% | 1,154 | $2K | |
| 85520 | <1% | 449 | $2K | |
| 87045 | <1% | 266 | $2K | |
| 80177 | <1% | 291 | $1K | |
| 82105 | <1% | 134 | $1K | |
| 80050 | General health panel | <1% | 116 | $1K |
| 87427 | <1% | 146 | $817.56 | |
| 84540 | <1% | 416 | $732.11 | |
| 89060 | <1% | 173 | $704.15 | |
| 82270 | <1% | 530 | $662.15 | |
| 87899 | <1% | 77 | $637.26 | |
| 86160 | <1% | 125 | $613.02 | |
| 87640 | <1% | 28 | $549.84 | |
| 86780 | <1% | 62 | $531.04 | |
| 86146 | <1% | 40 | $505.40 | |
| 85461 | <1% | 178 | $479.83 | |
| 87046 | <1% | 308 | $477.56 | |
| 82043 | <1% | 218 | $421.33 | |
| 86147 | <1% | 62 | $416.82 | |
| 82272 | <1% | 393 | $388.18 | |
| 85240 | <1% | 74 | $383.84 | |
| 82378 | <1% | 66 | $369.05 | |
| 86039 | <1% | 66 | $347.47 | |
| 86923 | <1% | 4,368 | $307.75 | |
| 85670 | <1% | 127 | $298.16 | |
| 86644 | <1% | 45 | $285.53 | |
| 84153 | <1% | 45 | $283.22 | |
| 87209 | <1% | 31 | $225.90 | |
| 80185 | <1% | 33 | $214.17 | |
| 87147 | <1% | 130 | $204.48 | |
| 85613 | <1% | 53 | $186.03 | |
| 86141 | <1% | 22 | $177.45 | |
| 80184 | <1% | 38 | $172.77 | |
| 85347 | <1% | 64 | $166.37 | |
| 87071 | <1% | 336 | $160.38 | |
| 84436 | <1% | 49 | $157.92 | |
| 82652 | <1% | 14 | $112.42 | |
| 87177 | <1% | 32 | $111.60 | |
| 84460 | <1% | 54 | $109.66 | |
| 84134 | <1% | 38 | $105.38 | |
| 82103 | <1% | 21 | $93.03 | |
| 86431 | <1% | 26 | $90.50 | |
| 84681 | <1% | 15 | $89.74 | |
| 80162 | <1% | 12 | $77.88 | |
| 84133 | <1% | 31 | $68.46 | |
| 87176 | <1% | 14 | $65.45 | |
| 82040 | <1% | 29 | $58.50 | |
| 82042 | <1% | 21 | $48.93 | |
| 82436 | <1% | 16 | $41.82 | |
| 80320 | <1% | 4,593 | $22.50 | |
| 87076 | <1% | 49 | $17.00 | |
| 80329 | <1% | 2,135 | $13.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.